The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 33%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (6 analysts) rates it strong buy, with a mean price target of $67.
Crane NXT, Co.
CXT · the NYSE · USD · Market cap $2.7B · 4,800 employees
Crane NXT, Co.
FAIL · Does not pass the screenAt the last full screen
2026-09-15
Screened 2026-09-15 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Crane NXT, Co. holds its Distribution at $47.54. The statistical read favours the sellers, held for 43 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 43 days |
| Price at the screen | $47.54 |
| Valuation | 19.64 trailing · 10.12 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.07 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 38.82% | Below 33% | Interest-bearing debt is 38.8% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 18.79% | Below 49% | Money owed to the company is 18.8% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.06% | Below 5% | Only 0.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-15 screen. The gold marker is the market price at the same screen. A 68.8% margin of safety to the base estimate.
Third-party analyst targets: 6 covering, consensus Strong Buy. The average target sits +40% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-15 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCoin counters and note checkers at a discount
Every time a vending machine swallows coins or a banknote machine checks for fakes, Crane NXT sits behind the transaction. The business splits between payment hardware and security authentication tech, both areas showing 17% revenue growth and an 8% profit margin. At 10.8 times forward earnings and a 57% gap to our $80 fair value, the numbers look attractive on paper, yet the opportunity rating sits at none.
We pass because the return on equity of just 11% and unknown moat give little conviction that the discount will close. Six analysts see a median target of $66, only modestly above the current $51 price, and the ethical screen clears without adding any extra edge.
Cyclical exposure in industrial machinery adds the usual trap risk, where low multiples often mark peak earnings rather than bargains. Currency moves and customer concentration could still bite. Analysis, not advice.
| Forward P/E | 10.1xcheap for a company growing this fast |
| Trailing P/E | 19.6xreasonably valued |
| EPS, trailing | 2.42 |
| EPS, forward | 4.70 |
| Revenue growth | +22.0%strong top-line growth |
| Profit margin | 7.8%thin but positive margins |
| Return on equity | 11.5%a modest return on shareholder capital |
| FCF yield | 8.76% |
| Dividend yield | 170.00% |
| Debt to equity | 1.14a meaningful debt load worth watching |
| Current ratio | 1.42adequate liquidity, worth monitoring |
| Beta | 1.07moves a little more than the market |
| Short interest, float | 0.19% |
| 52-week range | 35.71 - 69.00 |
| Market cap | $2.7B |
| Employees | 4,800 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCXT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 20.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 33%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (6 analysts) rates it strong buy, with a mean price target of $67.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 33%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (6 analysts) rates it strong buy, with a mean price target of $67.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $44.28 | -16.2% | $0.18 | $842 | -15.8% |
| 2 months | $43.68 | -15.1% | $0.18 | $853 | -14.7% |
| 3 months | $42.66 | -13.1% | $0.18 | $874 | -12.6% |
| 6 months | $54.13 | -31.5% | $0.36 | $692 | -30.8% |
| 1 year | $55.45 | -33.1% | $0.70 | $682 | -31.8% |
| 2 years | $59.45 | -37.6% | $1.36 | $647 | -35.3% |
| 3 years | $54.16 | -31.5% | $1.96 | $721 | -27.9% |
| 5 years | $29.81 | +24.4% | $3.22 | $1,352 | +35.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CXT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.